Navigation Links
Blue Belt Technologies, Inc. Closes Series A Financing
Date:9/30/2009

PITTSBURGH, Sept. 30 /PRNewswire/ -- Blue Belt Technologies, Inc., a Pittsburgh based medical device company developing the next generation of "smart" surgical instruments for use in orthopaedic and neurosurgery procedures, has closed on a $2.4 Million private equity Series A round of financing. The round was led by private investors and included the Pittsburgh Life Sciences Greenhouse and Innovation Works (Pittsburgh) and consisted of both new investments and the conversion of existing convertible notes.

"This investment will be used to finalize development and prepare for FDA submission of our core product, the Precision Freehand Sculptor, and will provide the resources necessary to prepare for full market release of our Orthopaedic and Neurosurgical products," said Craig S. Markovitz, Blue Belt Technologies, Inc. Chief Executive Officer. "We are pleased to have such an impressive group of investors and partners share our vision to provide a cost effective, highly capable solution for bone based computer assisted procedures."

"We continue to be impressed by Blue Belt's combination of innovative technology, passionate, experienced leadership and large market potential," said John W. Manzetti, PLSG President & CEO. "Blue Belt Technologies is a great example of the Pittsburgh Life Sciences Greenhouse model of taking technologies from Concept to Commercialization((TM) )and we look forward to the company's release into the Orthopaedic and Neurosurgical markets."

About Blue Belt Technologies, Inc.

Blue Belt Technologies, Inc., a Carnegie Mellon University spin off company, is developing the next generation of "smart" surgical instruments for use in orthopaedic and neurosurgery procedures. The company's patented Precision Freehand Sculptor (PFS) provides precise control to surgeons via an intelligent, handheld, computer assisted bone cutting tool. PFS provides the surgeon with a layer of safety and enhanced accuracy while performing bone shaping tasks through minimally invasive incisions. The Precision Freehand Sculpting (PFS) system utilizes a compact, handheld, intelligent tool to assist the surgeon in accurately cutting bone. Its control system monitors the position of the tool and adjusts the depth of cut (or disables cutting entirely) based on its proximity to bone that it should -- or should not -- remove.

Blue Belt Technologies, Inc. initially plans to release a computer assisted bone shaping product for spine, hip and knee based procedures via its "PFS Developers Kit" to allow existing surgical navigation platforms to integrate PFS capability seamlessly onto the estimated 8,000 navigation systems installed worldwide in a very cost effective manner. The Company is also developing an independent platform for other bone based procedures.

The Company is also a finalist for the Pittsburgh Technology Council's Tech 50 Awards recognizing Blue Belt Technologies, Inc. as one of southwestern Pennsylvania's most successful and innovative technology companies. The Company has also launched an updated website (www.bluebelttech.com), and has finalized its surgeon advisory board to include world renowned surgeons in both orthopaedics and neurosurgery.

About the Pittsburgh Life Sciences Greenhouse (PLSG)

The Pittsburgh Life Sciences Greenhouse (PLSG) provides capital investments and customized company formation and business growth services to western Pennsylvania's life sciences enterprises. The PLSG supports biosciences companies with promising innovations in the following concentrations: Biotechnology Tools, Diagnostics, Healthcare IT, Medical Devices and Therapeutics. The PLSG is propelling the sustainable growth of the region's life sciences economy by accelerating research and technology commercialization with seed and early-stage companies; connecting investors with their Investment Portfolio companies; expanding established life sciences ventures and relocating biomedical companies to Pennsylvania. www.plsg.com.

About Innovation Works (IW)

Innovation Works provides risk capital and business expertise to the most promising early-stage technology companies in Southwestern PA to help them grow and succeed. Innovation Works is one of the most active seed-stage investors in the country, having invested in more than 120 emerging technology companies since beginning their seed fund in 1999. Those companies have gone on to raise over $600 million in additional capital from a diverse set of VCs, private investors, strategic partners and other sources of capital. www.innovationworks.org.

SOURCE Blue Belt Technologies, Inc.


'/>"/>
SOURCE Blue Belt Technologies, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. ReBuilder Medical Technologies, Inc. Reports LOI With National DME Distributor
2. TriLink BioTechnologies, Inc. Announces Supply Agreement With Osmetech Molecular Diagnostics
3. Wound Management Technologies, Inc. Announces Conference Plans in Boston and Additional Clinical Research on CellerateRx(R)
4. Wound Management Technologies, Inc. Announces Agreement for Evidence Based Study for Diabetic Venous Ulcers
5. OxyBand Technologies, Inc. Hires a Leader in Medical Technology as Chief Technology Officer
6. Wound Management Technologies, Inc. Announces Evidence Based Study
7. Neurobiological Technologies, Inc. Presents Dosing Rationale for Viprinex(TM) (ancrod) at the European Stroke Conference
8. Neurobiological Technologies, Inc. and Buck Institute Partner to Develop Novel Treatment for Alzheimers Disease
9. Emisphere Technologies, Inc. Announces 2007 Third Quarter Financial Results
10. Palatin Technologies, Inc. Reports Initiation of Human Trials for the Treatment of Congestive Heart Failure
11. Rockwell Medical Technologies, Inc. Begins Dosing Patients for SFP Phase IIb Clinical Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... , June 24, 2016  Global Blood ... biopharmaceutical company developing novel therapeutics for the treatment ... today announced the closing of its previously announced ... stock, at the public offering price of $18.75 ... offering were offered by GBT. GBT estimates net ...
(Date:6/24/2016)... ALEXANDRIA, Va. , June 24, 2016 ... a set of recommendations that would allow ... information (HCEI) with entities that make formulary and coverage ... determine the "value" of new medicines. The ... that does not appear on the drug label, a ...
(Date:6/24/2016)... PUNE, India , June 24, 2016 ... "Pen Needles Market by Type (Standard Pen Needles, Safety ... 12mm), Therapy (Insulin, GLP-1, Growth Hormone), Mode of Purchase ... published by MarketsandMarkets, This report studies the market for ... is expected to reach USD 2.81 Billion by 2021 ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... June 25, 2016 , ... Experts from the ... AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the Hynes Convention Center in ... topics including advance care planning, healthcare costs and patient and family engagement. , ...
(Date:6/25/2016)... ... 2016 , ... "With 30 hand-drawn hand gesture animations, FCPX users can easily ... of Pixel Film Studios. , ProHand Cartoon’s package transforms over 1,300 hand-drawn pictures ... . Simply select a ProHand generator and drag it above media or text in ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson ... Recently, he has implemented orthobiologic procedures as a method for treating his patients. ... the first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons ...
(Date:6/24/2016)... , ... June 24, 2016 , ... A recent ... most people are unfamiliar with. The article goes on to state that individuals are ... many of these less common operations such as calf and cheek reduction. The Los ...
(Date:6/24/2016)... ... ... in a crisis. Her son James, eight, was out of control. Prone to extreme mood ... something upset him, he couldn’t control his emotions,” remembers Marcy. “If there was a ... children and say he was going to kill them. If we were driving on ...
Breaking Medicine News(10 mins):